Funded Tech Companies

Ability Biologics

Headquartered in Montreal, QC, Ability Biologics raised its funding from Alexandria Venture Investments, Charles River Laboratories and Theodorus.

Company Overview

Contact Information

Company Background Information

Overview

Develop innovative, targeted, immune modulating biotherapeutics to address unmet medical needs in patients with cancer and autoimmune diseases. The premier biotherapeutic targeting company: Our powerful AbiLeap� discovery engine combines massively parallel, continuously learning artificial intelligence (AI) with an extensive database of antigen-antibody interactions to generate fully human, IgG-based multispecific antibodies of exquisite selectivity and affinity.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

6/18/2024

Financing History

Management Team

Title

Name

Email & Social

Chairman

David de Graaf

        

Chief Executive Officer

Giles Day

        

Chief Operating Officer

Patrick Tremblay

        

Chief Technical Officer

Jean-Philippe Bürckert

        

Vice President

Matthew Clark

        

VP - R & D

Patricia Giblin

        

Company Investors

• Alexandria Venture Investments
• Charles River Laboratories
• Theodorus
• Amplitude Ventures
• Fonds de solidarite FTQ
• Investissement Quebec

Browse more funded tech companies:

Ability AI | ABILITY Network

Share this article

About Our Venture Capital Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary